Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +38.76%
#2 Purr Purr +34.19%
#3 Siren Siren +30.59%
#4 OriginTrail OriginTrail +18.15%
#5 UnifAI Network UnifAI Network +12.88%
#6 Zora Zora +12.79%
#7 Collect on Fanable Collect on Fanable +11.98%
#8 龙虾 (Lobster) 龙虾 (Lobster) +11.94%
#9 DigiByte DigiByte +11.71%
#10 Ethena Staked ENA Ethena Staked ENA +11.62%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Rangering i aksjer #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Aksjekurs
$50.82
Sist synkronisert: 2026-08-11
Markedsverdi
$102.09M
Endring (1 dag)
1.90%
Endring (1 år)
-
Land
US
Handel Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Kategori

Healthcare
EPS for Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Hemab Therapeutics Holdings, Inc. Common Stock er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Hemab Therapeutics Holdings, Inc. Common Stock fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH